Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

730 articles published

Biotech Stocks

Neurizon (ASX:NUZ) Clears FDA Hurdle for ALS Trial- Speculative Buy at 75% Off Highs?

Neurizon Therapeutics (ASX: NUZ) just hit a major milestone. The FDA has cleared its lead drug NUZ-001 to enter the HEALEY ALS Platform Trial at Massachusetts General Hospital, with patients now enrolling for this Phase 2/3 study in Q4 2025. This follows the FDA lifting its clinical hold back in October 2025. For investors, the…

ByUjjwal MaheshwariDecember 12, 20250Comments

Gold Stocks

Marmota (ASX:MEU) Surges 50% on Bonanza Gold at Greenewood- Buy Now or Wait for Stage 2?

Marmota (ASX: MEU) jumped around 50 per cent this week after reporting what management called "spectacular" gold results from its Greenewood project in South Australia's Gawler Craton. The standout grades include 109 g/t and 95 g/t gold from shallow depths, making these the best results in the region since Challenger was discovered back in 1995.…

ByUjjwal MaheshwariDecember 12, 20250Comments

Iron Ore Stocks

Fenix Resources (ASX: FEX) Surges 14% on Production Plan- Why This Iron Ore Stock Could Be a Buy

Fenix Resources (ASX: FEX) surged 14% to around 49.5 cents after releasing an ambitious three-year production plan that targets a ramp-up from 2.4 million tonnes in FY25 to as much as 6 million tonnes by FY28. The plan centres on the company's transition from its maturing Iron Ridge and Shine mines to the larger-scale Weld…

ByUjjwal MaheshwariDecember 12, 20250Comments

Mining Stocks

Perseus Mining Loses A$2.1bn Predictive Discovery Battle- Is (ASX: PRU) Now a Better Buy?

Perseus Mining's Failed Bid: What's Next for ASX: PRU? Perseus Mining (ASX: PRU) has withdrawn its A$2.1 billion takeover bid for Predictive Discovery. The move came after Robex Resources matched Perseus's offer before the December 10 deadline. Perseus had offered a 24.5 per cent premium, and Predictive's board called it a superior deal. However, Robex…

ByUjjwal MaheshwariDecember 12, 20250Comments

Healthcare Stocks

Is Rhythm Biosciences (ASX:RHY) a Buy After Securing NHS Expertise and US Distribution Deal?

Rhythm Biosciences (ASX: RHY) may finally be turning the corner. The company has secured NHS expertise to support its ColoSTAT bowel cancer blood test launch in the UK, while a separate deal with Catch Bio expands its geneType platform across the United States. For a stock trading at just A$25 to A$30 million market cap,…

ByUjjwal MaheshwariDecember 11, 20250Comments

Gold Stocks

Ramelius Resources (ASX:RMS) Rallies After A$250m Capital Return Program: Should You Buy the Gold Miner?

Ramelius Resources (ASX: RMS) jumped to an intraday high of A$3.71 this week before closing at A$3.57, up 5.6%, after announcing a A$250 million share buyback and doubling its minimum dividend to 2 cents per share. For gold investors, this signals management believes the stock is cheap and cash generation can reward shareholders while funding…

ByUjjwal MaheshwariDecember 11, 20250Comments

Healthcare Stocks

Orthocell (ASX:OCC) Surges 7% on First Hong Kong Sales: Is This Healthcare Stock a Buy as Asian Expansion Accelerates?

Orthocell (ASX: OCC) jumped 7% to A$1.09 on Wednesday after announcing its first commercial sales of Remplir in Hong Kong. The sales, made through distributor MontsMed, follow last month's first surgical case in the region and a strong debut at the Hong Kong Orthopaedic Association's 45th Annual Congress. For investors, this milestone shows the company…

ByUjjwal MaheshwariDecember 11, 20250Comments

Mining Stocks

Dateline Resources (ASX:DTR) Drops 20% on Legal Dispute: Is This a Buying Opportunity or Time to Sell?

Dateline Resources (ASX: DTR) dropped 20% to A$0.195 this week, and investors are asking a simple question: is this a chance to buy the dip or a warning sign to get out? The selloff came after US1 Critical Minerals (ASX: USC) filed legal proceedings against CEO Stephen Baghdadi over US rare earth tenements. Dateline has…

ByUjjwal MaheshwariDecember 11, 20250Comments

Gold Stocks

Moonlight Resources (ASX:ML8) Lists Tomorrow After A$10m IPO: Should You Buy This Gold and Critical Minerals Explorer?

Moonlight Resources (ASX: ML8) will make its ASX debut on 11 December 2025 after completing a A$10 million IPO at A$0.20 per share. The company is a gold and critical minerals explorer with a sizeable 5,200 square kilometre tenement portfolio spanning Queensland, Northern Territory, NSW, and Western Australia. What makes this listing worth watching is the…

ByUjjwal MaheshwariDecember 10, 20250Comments

Tech Stocks

PWR Holdings Gets New Leadership: What It Means for Investors After a Tough FY25

PWR Holdings backs internal leader for next phase PWR Holdings (ASX: PWH) announced yesterday that Chief Financial Officer Sharyn Williams will become its next CEO and Managing Director, marking a significant leadership transition for the high-tech cooling solutions company. Williams, who joined as CFO in January 2025, will take over once a replacement is found,…

ByUjjwal MaheshwariDecember 10, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

Neurizon (ASX:NUZ) Clears FDA Hurdle for ALS Trial- Speculative Buy at 75% Off Highs?

Marmota (ASX:MEU) Surges 50% on Bonanza Gold at Greenewood- Buy Now or Wait for Stage 2?

Fenix Resources (ASX: FEX) Surges 14% on Production Plan- Why This Iron Ore Stock Could Be a Buy

Perseus Mining Loses A$2.1bn Predictive Discovery Battle- Is (ASX: PRU) Now a Better Buy?

Is Rhythm Biosciences (ASX:RHY) a Buy After Securing NHS Expertise and US Distribution Deal?

Ramelius Resources (ASX:RMS) Rallies After A$250m Capital Return Program: Should You Buy the Gold Miner?

Orthocell (ASX:OCC) Surges 7% on First Hong Kong Sales: Is This Healthcare Stock a Buy as Asian Expansion Accelerates?

Dateline Resources (ASX:DTR) Drops 20% on Legal Dispute: Is This a Buying Opportunity or Time to Sell?

Moonlight Resources (ASX:ML8) Lists Tomorrow After A$10m IPO: Should You Buy This Gold and Critical Minerals Explorer?

PWR Holdings Gets New Leadership: What It Means for Investors After a Tough FY25

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here